Trial Profile
A randomised, double-blind, placebo-controlled, 4-way crossover clinical trial to assess the efficacy, safety, tolerability and pharmacokinetics of single doses of LAS100977 administered by inhalation to stable asthma patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Mar 2015
Price :
$35
*
At a glance
- Drugs Abediterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Almirall S.A.
- 21 Apr 2012 Official title amended as reported by European Clinical Trials Database.
- 21 Apr 2012 New source identified and integrated (EudraCT2008-004756-69: European Clinical Trials Database).
- 11 May 2010 Forest Laboratories reports that resutls will be presented at the American Thoracic Society International Conference in May 2010.